Juan Francisco Rodríguez Moreno-rekin lankidetzan egindako argitalpenak (6)

2025

  1. Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids

    Journal of Experimental and Clinical Cancer Research, Vol. 44, Núm. 1

  2. Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study

    Clinical and Translational Oncology, Vol. 27, Núm. 6, pp. 2719-2730

  3. Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 31, Núm. 9, pp. 1644-1656

2024

  1. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

    The Journal of clinical investigation, Vol. 134, Núm. 10

2023

  1. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2432-2440